Seyed Ali Mousavi Shaegh received Ph.D. in 2012 from Nanyang Technological University, Singapore, in Mechanical engineering. He joined Harvard University, Brigham and Women’s Hospital and Harvard-MIT Division of Health Sciences and Technology (HST), in 2014 as a postdoc fellow after a two-year research appointment at Singapore Institute of Manufacturing Technology (a research institute of Agency for Science, Technology and Research, A*STAR). Currently, he is an assistant professor of Biomedical Engineering at Mashhad University of Medical Sciences, in the School of Medicine (Clinical Research Unit and Orthopedic Research Center) where he leads a research team with multidisciplinary background including engineering, pharmaceutical sciences and medicine. He is recipient of many prestigious national and international awards including Iran’s National Elite Foundation Award (2020) and Mustafa-Kanz Prize (2022). Currently, he serves as a board member of National Institute for Medical Research Development (NIMAD) that is the leading funding agency for medical research grant in Iran. Dr. Shaegh is also an entrepreneur. He is co-founder and CEO of Nanosynthes Co. which is manufacturer of instruments for the production of drug nanocarriers based on microfluidic technology. Mousavi’s research interests are mainly focused on design, fabrication, and testing of medical devices and implants, as well as microfluidic systems for diagnostics, drug synthesis and testing